Company reported positive Phase 2b QUALITY study topline results for enobosarm + semaglutide (Wegovy®) with study meeting ...

The Company's Board of Directors (the "Board”) approved payment of the $0.0075 per share per month dividend beginning in ...

H1 2024-25 results in line with expectations Operating verticals revenues of €600m up 3.9% like-for-like1 Adjusted EBITDA margin of 55.2% FY 2024-25 objectives confirmed ...

Universal Security Instruments, Inc. (NYSE AMEX: UUU) today announced results for its fiscal third quarter and nine months ended December 31, 2024.

Palatin Technologies, Inc. (AMEX: PTN) Q2 2025 Earnings Call Transcript February 13, 2025 ...

Company reported positive Phase 2b QUALITY study topline results for enobosarm + semaglutide (Wegovy®) with study meeting prespecified primary endpoint of preservation of lean mass as well as greater ...

Follow all the latest UEFA Conference League 2024/2025 news from the official UEFA.com site. Includes latest news stories, ...

The Cupertino-based company posted a four percent year-over-year increase, reaching $124.3 billion in revenue.

Operator: Greetings, and welcome to the Great Elm Group Fiscal 2025 Second Quarter Conference Call. At this time, all ...

Denver’s Jamal Murray is climbing the Nuggets’ franchise leaderboard for most points in a game. Murray notched a career-high ...

The Charlotte Hornets have made their second trade of the calendar year, completing a draft pick swap with the Oklahoma City ...

Needham analyst Ryan Koontz upgraded Viavi Solutions (NASDAQ:VIAV) from Hold to Buy and a $15 price forecast after the company reported its quarterly print Thursday. In line with Koontz’s preview, ...